The results showed that the expression of TWIST2 and EMT markers was significantly increased after knockdown of ACOT12 with siRNA, which indicated that depletion of ACOT12 was able to enhance mesenchymal transition in glioma cells (Fig. 6A, B). Here, TWIST2 is linked to central nervous system cancer.